ニュージャージーにおける過体重の臨床試験
ニュージャージー内の拠点で、過体重に関する16件の研究が参加者を募集しています。
ニュージャージー内の都市
公式研究テキスト（英語）
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Warren, Warren Township
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Somerset
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Hackensack University Medical Center, Hackensack
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Hypertension & Nephrology Association, Eatontown
- IMA Clinical Research Warren, Warren Township
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Eatontown
- Research Site, Somerset
- Research Site, Warren Township
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- CardioMetabolic Collaborative Clinic, Somerset
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- IMA Clinical Research Warren, Warren Township
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Jersey City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Clinical Research of Philadelphia, Pennington
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT06897475A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Premier Research, Trenton
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Psoriasis Treatment Center of Central New Jersey, East Windsor
- Care Access - Hoboken, Hoboken
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Premier Research, Trenton
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Jersey City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725Metabolic Health, Bones and Nuts During Weight Loss in Adults
- Rutgers University - NJ Inst Food Nutrition & Health, New Brunswick
被験者募集中健康なボランティア歓迎
50歳〜75歳 · 全性別 · 2026/05/13更新 · NCT06949280A Study of a Weight Loss Intervention in People With Endometrial Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
被験者募集中早期第1相
18歳以上 · 女性 · 2026/04/13更新 · NCT06751589A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- Frontage Clinical Services, Inc., Secaucus
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/03/12更新 · NCT07465965ClinicalTrials.govより、2026/10/03時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。